- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 22.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 18.83M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 7.98M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $10.73K |
| Capex | Q1 2026 · Mar 31, 2025 | $26.99K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.06M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$713.92K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.29M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $6.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.26M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $4.09M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.32M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.85M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.17M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.56M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.92M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.63M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $7.42M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.24M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $14.18M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.37 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.37 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $409.96K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $203.17K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $81.53K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $8.03K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.21M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$10.9M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.45M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.46M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $225.58K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $617.26K |
| Revenue | Q1 2026 · Mar 31, 2026 | $344.92K |
| Revenue | Q1 2026 · Mar 31, 2025 | $969.38K |